Jasper Therapeutics Inc
General ticker "JSPR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $333.3M
Jasper Therapeutics Inc follows the US Stock Market performance with the rate: 32.5%.
Estimated limits based on current volatility of 4.2%: low 20.66$, high 22.49$
Factors to consider:
- Current price 111.9% above estimated high
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.52$, 10.44$]
- 2024-12-30 to 2025-12-30 estimated range: [2.87$, 7.95$]
Financial Metrics affecting the JSPR estimates:
- Negative: Non-GAAP EPS, $ of -6.20 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -47.73 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
Short-term JSPR quotes
Long-term JSPR plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $36.83MM | $51.20MM | $68.86MM |
Operating Income | $-36.83MM | $-51.20MM | $-68.86MM |
Non-Operating Income | $-6.16MM | $13.51MM | $2.77MM |
R&D Expense | $25.42MM | $34.63MM | $51.78MM |
Income(Loss) | $-42.99MM | $-37.69MM | $-66.09MM |
Taxes | $0.00MM | $-13.51MM | $-1.63MM |
Profit(Loss) | $-42.99MM | $-24.17MM | $-64.47MM |
Stockholders Equity | $69.52MM | $35.99MM | $78.44MM |
Inventory | $0.55MM | $0.00MM | $0.00MM |
Assets | $93.65MM | $48.36MM | $94.89MM |
Operating Cash Flow | $-33.68MM | $-45.86MM | $-52.07MM |
Capital expenditure | $2.43MM | $0.58MM | $0.27MM |
Investing Cash Flow | $-2.43MM | $-0.58MM | $-0.27MM |
Financing Cash Flow | $100.97MM | $0.06MM | $100.97MM |
Earnings Per Share* | $-21.05 | $-6.63 | $-6.18 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.